Chaparral Labs
back to search

protein

Malonate--CoA ligase ACSF3, mitochondrial

ACSF3
protein:Q4G176disease:adad:direction:down

Gene

ACSF3

Organism

Homo sapiens(9606)

Length

576 aa

Mass

64,130 Da

AI summarysource-grounded · cited inline
claude-haiku-4-5-20251001

ACSF3 (malonate–CoA ligase) is a mitochondrial enzyme that catalyzes activation of malonate and methylmalonate into their CoA thioesters, supporting intramitochondrial fatty acid synthesis (UniProt: Q4G176). The protein may preferentially act on very-long-chain substrates. In humans, ACSF3 mutations cause combined malonic and methylmalonic aciduria (CMAMMA, MIM 614265), a metabolic disorder presenting with neurological manifestations including seizures, cognitive decline, and developmental delay.

ACSF3 is relevant to Alzheimer's disease, where it shows reduced abundance in post-mortem AD brain tissue compared to age-matched controls (Chaparral AD proteomics). The mean log2 fold-change was −0.44 across analyzed subcellular fractions, indicating down-regulation. This reduction may reflect impaired mitochondrial fatty acid metabolism in the AD brain, potentially contributing to metabolic dysfunction associated with neurodegeneration.

Generated from the curated entity record below. May contain errors — verify against source links.

Proteomics Evidence · AD

↓ Down in AD

P3

-0.444

P2

not detected

S2

not detected

S3

not detected

Mean log₂FC across detected fractions: -0.4442 (1 of 4 fractions detected)

Human post-mortem AD brain vs age-matched controls, TMT-labeled, 4 subcellular fractions (P2, P3, S2, S3), DDA proteomics.

Related Publications

Browse all →

Function

Catalyzes the initial reaction in intramitochondrial fatty acid synthesis, by activating malonate and methylmalonate, but not acetate, into their respective CoA thioester (PubMed:21841779, PubMed:21846720). May have some preference toward very-long-chain substrates (PubMed:17762044)

Disease associations

  • Combined malonic and methylmalonic aciduriaCMAMMA

    A metabolic disease characterized by malonic and methylmalonic aciduria, with urinary excretion of much larger amounts of methylmalonic acid than malonic acid, in the presence of normal malonyl-CoA decarboxylase activity. Clinical features include coma, ketoacidosis, hypoglycemia, failure to thrive, microcephaly, dystonia, axial hypotonia and/or developmental delay, and neurologic manifestations including seizures, psychiatric disease and/or cognitive decline.

Sources

Last updated 5/8/2026, 6:37:40 AM